The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Qinghaosu (Artemisinin): The Price of Success
Abstract
Artemisinin and its derivatives have become essential components of antimalarial treatment. These plant-derived peroxides are unique among antimalarial drugs in killing the young intraerythrocytic malaria parasites, thereby preventing their development to more pathological mature stages. This results in rapid clinical and parasitological responses to treatment and life-saving benefit in severe malaria. Artemisinin combination treatments (ACTs) are now first-line drugs for uncomplicated falciparum malaria, but access to ACTs is still limited in most malaria-endemic countries. Improved agricultural practices, selection of high-yielding hybrids, microbial production, and the development of synthetic peroxides will lower prices. A global subsidy would make these drugs more affordable and available. ACTs are central to current malaria elimination initiatives, but there are concerns that tolerance to artemisinins may be emerging in Cambodia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“iron-catalysed radical formation is also significantly involved in the antimalarial (i.e. cytotoxic) mode of action of artemisinin [1494,1496-1504], and this reaction is in fact inhibited by iron chelators [1505] such that a combined artemisinin-chelator therapy would be contraindicated.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1504]
Citations
Cites
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Bhattarai, A., Ali, A. S., Kachur, S. P., Mårtensson, A., Abbas, A. K., Khatib, R., Al-mafazy, A.-W., Ramsan, M., Rotllant, G., Gerstenmaier, J. F., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040309 · Cited by 647
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo
White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575
Self-citationWhite, N., Nosten, F., Looareesuwan, S., Watkins, W., Marsh, K., Snow, R., Kokwaro, G., Ouma, J., Hien, T., Molyneux, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07367-x · Cited by 543
Self-citationArtesunate combinations for treatment of malaria: meta-analysis
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15162-8 · Cited by 538
Self-citationThiers, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70110-2 · Cited by 512
Research works printed but not linked: 11
- Qinghaosu Antimalarial Coordinating Research Group, Chin. Med. J. (Engl.)92, 811 (1979).
- J. B. Jianget al., Lancet2, 285 (1982).
- G. Q. Liet al., J. Tradit. Chin. Med.2, 125 (1982).
- W. Peters, Pharmacol. Ther.47, 499 (1990).
- F. ter Kuileet al., Exp. Parasitol.76, 86 (1993).
- P. Q. Chenet al., Chin. Med. J. (Engl.)107, 709 (1994).
- R. Jambouet al., Lancet366, 1960 (2005). · doi:10.1016/s0140-6736(05)67787-2
- I. Nakase, H. Lai, N. P. Singh, T. Sasaki, Int. J. Pharm.354, 28 (2007).
- International Artemisinin Study Group, Lancet363, 9 (2004). · DOI · Paper page
- M. van Vugt, Am. J. Trop. Med. Hyg.62, 65 (2000).
- Wkly. Epidemiol. Rec.82, 360 (2007).
Cited by
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Self-citationDiscovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
“of derivatives, such as sodium artensunate or artemether, that are nowadays widely used to treat malaria (Klayman, 1985; White, 2008).”
BackgroundSpiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924
Self-citationSynergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
Caesar, L. K., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c9np00011a · Cited by 881
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Doenhoff, M. J., Cioli, D., & Utzinger, J. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328318978f · Cited by 806
Bousema, T., & Drakeley, C. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-10 · Cited by 746
“reductions in parasitemia (3, 363, 509), and treatment with TABLE 2.”
Westfall, P. J., Pitera, D. J., Lenihan, J. R., Eng, D., Woolard, F. X., Regentin, R., Horning, T., Tsuruta, H., Melis, D. J., Owens, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110740109 · Cited by 722
“Chemical synthesis of artemisinin is not economically feasible because of the complexity and low yield of the process (7), however semisynthesis of artemisinin following microbial production of a precursor molecule may be feasible (6).”
BackgroundSemi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development
Paddon, C. J., & Keasling, J. D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3240 · Cited by 675
Flow chemistry syntheses of natural products
Pastre, J. C., Browne, D. L., & Ley, S. V. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60246j · Cited by 658
Artemisinin resistance: current status and scenarios for containment
Dondorp, A. M., Yeung, S., White, L., Nguon, C., Day, N. P. J., Socheat, D., & von Seidlein, L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2331 · Cited by 645
“In the 1970s the chemical structure of a sesquiterpene peroxide with powerful antimalarial properties (artemisinin) was identified, and several more potent derivatives were synthesized, including artesunate, artemether and dihydroartemisini”
BackgroundKeiser, J., & Utzinger, J. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-09 · Cited by 629
“, synthetic trioxolanes [OZs]), best known for their antimalarial properties (113, 116), and the Chinese anthelmintic drug tribendimidine (122) might be further developed for use against food-borne trematodiases (54).”
BackgroundMalaria biology and disease pathogenesis: insights for new treatments
Miller, L. H., Ackerman, H. C., Su, X.-Z., & Wellems, T. E. (2013) · Nature Medicine · doi:10.1038/nm.3073 · Cited by 582
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Eastman, R. T., & Fidock, D. A. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2239 · Cited by 568
“falciparum in vitro and in vivo and can produce faster parasite clearance and fever resolution times than any other licensed antimalarial, including quinin”
BackgroundKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“cytotoxic) mode of action of artemisinin [1336; 1338-1346], and this reaction is in fact inhibited by iron chelators [1347] such that a combined artemisinin-chelator therapy would be contraindicated.”
BackgroundContinuous‐Flow Synthesis of the Anti‐Malaria Drug Artemisinin
Lévesque, F., & Seeberger, P. H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107446 · Cited by 516
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Menard, D., & Dondorp, A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025619 · Cited by 499
Yu, Z.-X., Li, J.-X., Yang, C.-Q., Hu, W.-L., Wang, L.-J., & Chen, X.-Y. (2012) · Molecular Plant · doi:10.1093/mp/ssr087 · Cited by 481
“Artemisinin and its semi-synthetic derivatives are extensively used in the treatment of malaria, mostly in artemisinin-based combination therapies (ACTs) so as to reduce resistance (Duffy and Mutabingwa, 2006; Haynes, 2006; White, 2008).”
BackgroundYeung, B. K. S., Zou, B., Rottmann, M., Lakshminarayana, S. B., Ang, S. H., Leong, S. Y., Tan, J., Wong, J., Keller-Maerki, S., Fischli, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100410f · Cited by 432
Vaou, N., Stavropoulou, E., Voidarou, C. (., Tsakris, Z., Rozos, G., Tsigalou, C., & Bezirtzoglou, E. (2022) · Antibiotics · doi:10.3390/antibiotics11081014 · Cited by 406
“(Asteraceae), are accepted as safe and potent antimalarial agents [68].”
BackgroundPoor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
Nayyar, G. M., Breman, J. G., Newton, P. N., & Herrington, J. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70064-6 · Cited by 410
A Major Genome Region Underlying Artemisinin Resistance in Malaria
Cheeseman, I. H., Miller, B. A., Nair, S., Nkhoma, S., Tan, A., Tan, J. C., Al Saai, S., Phyo, A. P., Moo, C. L., Lwin, K. M., et al. (2012) · Science · doi:10.1126/science.1215966 · Cited by 381
Self-citationDiscovery, mechanisms of action and combination therapy of artemisinin
Cui, L., & Su, X.-Z. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.68 · Cited by 371
“177 Yeung S, Van Damme W, Socheat D, White NJ, Mills A. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malaria J. 7, 96 (2008).”
Charman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brun, R., Campbell, M., Charman, W. N., Chiu, F. C. K., Chollet, J., Craft, J. C., Creek, D. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015762108 · Cited by 373
“The clinical effectiveness of the ART derivatives stems from their rapid onset of action and activity against all erythrocytic stages of the parasite, a feature unique among currently available antimalarial drugs (6).”
BackgroundTsuruta, H., Paddon, C. J., Eng, D., Lenihan, J. R., Horning, T., Anthony, L. C., Regentin, R., Keasling, J. D., Renninger, N. S., & Newman, J. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004489 · Cited by 363
“Chemical synthesis of artemisinin is not practical due to its complexity and low yield [4].”
BackgroundArtemisinin Action and Resistance in Plasmodium falciparum
Tilley, L., Straimer, J., Gnädig, N. F., Ralph, S. A., & Fidock, D. A. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.05.010 · Cited by 359
“This pharmacodynamic hallmark is of critical benefit in treating severe malaria and reversing its otherwise lethal course [5, 6].”
Methylerythritol Phosphate Pathway of Isoprenoid Biosynthesis
Zhao, L., Chang, W.-C., Xiao, Y., Liu, H.-W., & Liu, P. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052010-100934 · Cited by 353
“drug (126) used widely with other antimalarial drugs in artemisinin-based combination therapies (ACTs) (127).”
Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Witkowski, B., Lelièvre, J., López Barragán, M. J., Laurent, V., Su, X.-Z., Berry, A., & Benoit-Vical, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01636-09 · Cited by 317
“More than a million doses of ACT are administered to treat malaria each year, particularly after the recommendation of World Health Organization (WHO) in 2005 (26).”
BackgroundMa, N., Zhang, Z., Liao, F., Jiang, T., & Tu, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107658 · Cited by 310
Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome
Bridgford, J. L., Xie, S. C., Cobbold, S. A., Pasaje, C. F. A., Herrmann, S., Yang, T., Gillett, D. L., Dick, L. R., Ralph, S. A., Dogovski, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06221-1 · Cited by 297
Carrara, V. I., Zwang, J., Ashley, E. A., Price, R. N., Stepniewska, K., Barends, M., Brockman, A., Anderson, T., McGready, R., Phaiphun, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004551 · Cited by 281
“In 2004, MAS2 was extended to all provinces along the borders with Myanmar and Cambodia, following evidence from these areas of inadequate clinical cure rates with mefloquine alone, or MSP [4–6].”
BackgroundSelf-citationTriterpenoid biosynthesis and engineering in plants.
Sawai, S., & Saito, K. (2011) · Frontiers in Plant Science · doi:10.3389/fpls.2011.00025 · Cited by 272
“Semi-synthesis of artemisinin from artemisinic acid (Roth and Acton, 1989) derived by fermentation could be an alternative lower-cost supply method (White, 2008).”
MethodBousema, T., Okell, L., Shekalaghe, S., Griffin, J. T., Omar, S., Sawa, P., Sutherland, C., Sauerwein, R., Ghani, A. C., & Drakeley, C. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-136 · Cited by 269
“This gradual decline in gametocyte density was interpreted as the natural decay of gametocytes after peak gametocytocidal drug levels had waned [41].”
Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial Activation
Wang, J., Huang, L., Li, J., Fan, Q., Long, Y., Li, Y., & Zhou, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009582 · Cited by 256
“fight against this devastating disease [1,2].”
Teuscher, F., Gatton, M. L., Chen, N., Peters, J., Kyle, D. E., & Cheng, Q. (2010) · The Journal of Infectious Diseases · doi:10.1086/656476 · Cited by 255
“Most concentrations of DHA used in our experiments (200–500 ng/mL) were 1100-fold higher than the reported 90% inhibitory concentration (IC90) for these parasites in a standard 3-day IC90 assay and were within the range of peak plasma DHA concentrations in humans treated with artemisinin derivatives [20].”
Industrial natural product chemistry for drug discovery and development
Bauer, A., & Brönstrup, M. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70058e · Cited by 255
Antimalarial drug discovery: progress and approaches
Siqueira-Neto, J. L., Wicht, K. J., Chibale, K., Burrows, J. N., Fidock, D. A., & Winzeler, E. A. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00772-9 · Cited by 240
Zhang, F., Fu, X., Lv, Z., Lu, X., Shen, Q., Zhang, L., Zhu, M., Wang, G., Sun, X., Liao, Z., et al. (2015) · Molecular Plant · doi:10.1016/j.molp.2014.12.004 · Cited by 248
“M action, and absence of serious side effects (White, 2008).”
21st Century natural product research and drug development and traditional medicines
Ngo, L. T., Okogun, J. I., & Folk, W. R. (2013) · Natural Product Reports · doi:10.1039/c3np20120a · Cited by 248
Olsson, M. E., Olofsson, L. M., Lindahl, A.-L., Lundgren, A., Brodelius, M., & Brodelius, P. E. (2009) · Phytochemistry · doi:10.1016/j.phytochem.2009.07.009 · Cited by 241
Adams, M., Berset, C., Kessler, M., & Hamburger, M. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.11.010 · Cited by 242
Sisowath, C., Petersen, I., Veiga, M. I., Mårtensson, A., Premji, Z., Björkman, A., Fidock, D. A., & Gil, J. P. (2009) · Journal of Infectious Diseases · doi:10.1086/596738 · Cited by 231
“In Southeast Asia, decreased efficacy of artesunate-MQ treatment has been reported [36], presumably because of MQ resistance caused by an increased pfmdr1 copy number [37].”
BackgroundUtzinger, J., N’Goran, E. K., Caffrey, C. R., & Keiser, J. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2010.08.020 · Cited by 227
Seeberger, P. H. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01210 · Cited by 213
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin
Klonis, N., Xie, S. C., McCaw, J. M., Crespo-Ortiz, M. P., Zaloumis, S. G., Simpson, J. A., & Tilley, L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217452110 · Cited by 213
“Clinically, ARTs are fast acting due to their broad spectrum activity against blood-stage parasites, providing a prompt response that is critical for treating severe malaria (1).”
BackgroundMethodInfluentialZhang, K., Shafer, B. M., Demars, M. D., Stern, H. A., & Fasan, R. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3073462 · Cited by 205
Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice
Keiser, J., Chollet, J., Xiao, S.-H., Mei, J.-Y., Jiao, P.-Y., Utzinger, J., & Tanner, M. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000350 · Cited by 201
“Interestingly, the artemisinins (e.g., artemether and artesunate), which are essential components of malaria treatment and control [18], also possess antischistosomal properties [19,20].”
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
Bergquist, R., Utzinger, J., & Keiser, J. (2017) · Infectious Diseases of Poverty · doi:10.1186/s40249-017-0286-2 · Cited by 195
“Briefly, leaf extracts from the plant Artemisia annua recommended in Chinese traditional medicine against malaria (and other ailments), constituted the starting point for the development of the artemisinin-based combination therapy (ACT) currently in use against this infection [92, 93].”
BackgroundChen, X., Gao, C., Guo, L., Hu, G., Luo, Q., Liu, J., Nielsen, J., Chen, J., & Liu, L. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00804 · Cited by 193
The chemistry of heterocycles in the 21st century
Charushin, V. N., Verbitskiy, E. V., Chupakhin, O. N., Vorobyeva, D. V., Gribanov, P. S., Osipov, S. N., Ivanov, A. V., Martynovskaya, S. V., Sagitova, E. F., Dyachenko, V. D., et al. (2024) · Russian Chemical Reviews · doi:10.59761/rcr5125 · Cited by 182
Artemisia annua, a Traditional Plant Brought to Light
Septembre-Malaterre, A., Lalarizo Rakoto, M., Marodon, C., Bedoui, Y., Nakab, J., Simon, E., Hoarau, L., Savriama, S., Strasberg, D., Guiraud, P., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144986 · Cited by 190
Mirzaei, S., Gholami, M. H., Hashemi, F., Zabolian, A., Farahani, M. V., Hushmandi, K., Zarrabi, A., Goldman, A., Ashrafizadeh, M., & Orive, G. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.020 · Cited by 186
Isoprenoid drugs, biofuels, and Chemicals–Artemisinin, farnesene, and beyond
George, K. W., Alonso-Gutierrez, J., Keasling, J. D., & Lee, T. S. (2015) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2014_288 · Cited by 185
“artemisinin, this is not a feasible or cost-effective option [21].”
BackgroundThe last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
Maude, R. J., Pontavornpinyo, W., Saralamba, S., Aguas, R., Yeung, S., Dondorp, A. M., Day, N. P., White, N. J., & White, L. J. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-31 · Cited by 184
“Recent data from western Cambodia provides the first objective evidence that efficacy of this essential drug class may be declining [5-7].”
BackgroundResultSelf-citationThe emergence of artemisinin partial resistance in Africa: how do we respond?
Rosenthal, P. J., Asua, V., Bailey, J. A., Conrad, M. D., Ishengoma, D. S., Kamya, M. R., Rasmussen, C., Tadesse, F. G., Uwimana, A., & Fidock, D. A. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00141-5 · Cited by 180
Molecular docking for virtual screening of natural product databases
Ma, D.-L., Chan, D. S.-H., & Leung, C.-H. (2011) · Chem. Sci. · doi:10.1039/c1sc00152c · Cited by 175
The Symbiotic Relationship Between Drug Discovery and Organic Chemistry
Grygorenko, O. O., Volochnyuk, D. M., Ryabukhin, S. V., & Judd, D. B. (2020) · Chemistry – A European Journal · doi:10.1002/chem.201903232 · Cited by 174
Mok, S., Imwong, M., Mackinnon, M. J., Sim, J., Ramadoss, R., Yi, P., Mayxay, M., Chotivanich, K., Liong, K.-Y., Russell, B., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-391 · Cited by 169
“Background Artemisinin combination therapy (ACT) is recommended by the World Health Organization as the firstline treatment for falciparum malaria in all endemic regions [1,2].”
BackgroundSelf-citationArtemisinin-Resistant Malaria: Research Challenges, Opportunities, and Public Health Implications
Fairhurst, R. M., Nayyar, G. M. L., Breman, J. G., Hallett, R., Vennerstrom, J. L., Duong, S., Ringwald, P., Wellems, T. E., Plowe, C. V., & Dondorp, A. M. (2012) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0025 · Cited by 170
Rosenthal, P. J., Asua, V., & Conrad, M. D. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01008-2 · Cited by 162
Artemisinin, a miracle of traditional Chinese medicine
Kong, L. Y., & Tan, R. X. (2015) · Natural Product Reports · doi:10.1039/c5np00133a · Cited by 169
Plant-Derived Products as Antibacterial and Antifungal Agents in Human Health Care
Kokoska, L., Kloucek, P., Leuner, O., & Novy, P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180831144344 · Cited by 165
Data Resources for the Computer-Guided Discovery of Bioactive Natural Products
Chen, Y., de Bruyn Kops, C., & Kirchmair, J. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00341 · Cited by 161
Benefits of using multiple first-line therapies against malaria
Boni, M. F., Smith, D. L., & Laxminarayan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804628105 · Cited by 172
“Extensive resistance has yet to be detected to artemisinin drugs, but there is concern that resistance could emerge and spread rapidly (4).”
In Vivo Parasitological Measures of Artemisinin Susceptibility
Stepniewska, K., Ashley, E. A., Lee, S. J., Anstey, N. M., Barnes, K. I., Bình, T. Q., D’Alessandro, U., Day, N. P. J., de Vries, P. J., Dorsey, G., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/650301 · Cited by 161
“falciparum malaria has developed there [2, 13].”
BackgroundSelf-citationEstimated Under-Five Deaths Associated with Poor-Quality Antimalarials in Sub-Saharan Africa
Renschler, J. P., Walters, K. M., Newton, P. N., & Laxminarayan, R. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0725 · Cited by 163
“authenticity, and a large, unregulated private sector for purchasing pharmaceuticals.(5,11,12) The World Health Organiza-”
A Concise Synthesis of (+)-Artemisinin
Zhu, C., & Cook, S. P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3061479 · Cited by 153
Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities
Whitty, C. W. M., Chandler, C., Ansah, E., Leslie, T. J., & Staedke, S. G. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-s1-s7 · Cited by 151
“East Asia, there is already a concern about an increasing tolerance to artemisinins by parasites [59].”
BackgroundAnti‐Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives
Shi, C., Li, H., Yang, Y., & Hou, L. (2015) · Mediators of Inflammation · doi:10.1155/2015/435713 · Cited by 151
“Artemisinin and its derivatives are currently considered the most effective drug in treating cerebral malaria and chloroquine resistant falciparum malaria [2, 3].”
BackgroundArtemisinin biosynthesis in growing plants of Artemisia annua. A 13CO2 study
Schramek, N., Wang, H., Römisch-Margl, W., Keil, B., Radykewicz, T., Winzenhörlein, B., Beerhues, L., Bacher, A., Rohdich, F., Gershenzon, J., et al. (2010) · Phytochemistry · doi:10.1016/j.phytochem.2009.10.015 · Cited by 150
Antimalarial Drugs: Modes Of Action And Mechanisms Of Parasite Resistance
Müller, I. B., & Hyde, J. E. (2010) · Future Microbiology · doi:10.2217/fmb.10.136 · Cited by 172
“In fact the anti malarial effect of this plant extract was already well known in traditional Chinese medicine [82,124] and is thus most probably the oldest chemotherapeutic agent against malaria.”
BackgroundAnderson, T., Nair, S., Nkhoma, S. C., Williams, J. T., Imwong, M., Yi, P., Socheat, D., Das, D., Chotivanich, K., Day, N., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/651562 · Cited by 145
“(1) If reduced CR provides a selective advantage to parasites in the face of artemisinin based treatment regimens as suggested by the unusually high treatment failure rates in this area, then the alleles that underlie slow CR are expected to spread within populations, unless associated fitness costs outweigh selective…”
BackgroundSelf-citationChemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets
Yuan, J., Cheng, K. C.-C., Johnson, R. L., Huang, R., Pattaradilokrat, S., Liu, A., Guha, R., Fidock, D. A., Inglese, J., Wellems, T. E., et al. (2011) · Science · doi:10.1126/science.1205216 · Cited by 142
Current and emerging strategies to combat antimalarial resistance
Rasmussen, C., Alonso, P. L., & Ringwald, P. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1962291 · Cited by 148
“To prevent recurrent parasitemia, 7 days of treatment was needed when using artemisinin or an artemisinin derivative as a monotherapy [39,40].”
BackgroundHartwig, C. L., Rosenthal, A. S., D’Angelo, J. G., Griffin, C. E., Posner, G. H., & Cooper, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.015 · Cited by 147
“Therapeutic plasma concentration of ART derivatives can achieve micromolar levels shortly after administration [43].”
In vitroandin vivotrematode models for chemotherapeutic studies
Keiser, J. (2009) · Parasitology · doi:10.1017/s0031182009991739 · Cited by 155
“We have recently described that the semi-synthetic artemisinin derivatives artemether and artesunate, which are essential components of malaria therapy (White, 2008) and synthetic derivatives possess a broad range of trematodicidal activities (Keiser andT ab le 2 .”
BackgroundPoor quality vital anti-malarials in Africa - an urgent neglected public health priority
Newton, P. N., Green, M. D., Mildenhall, D. C., Plançon, A., Nettey, H., Nyadong, L., Hostetler, D. M., Swamidoss, I., Harris, G. A., Powell, K., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-352 · Cited by 140
“With the implementation of pivotal artemisinin-based combination therapy (ACT) throughout malarious Africa and attempts to make it accessible and affordable, hope of controlling malaria has been rekindled [2,3].”
BackgroundGuo, Y., Dong, J., Zhou, T., Auxillos, J., Li, T., Zhang, W., Wang, L., Shen, Y., Luo, Y., Zheng, Y., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv464 · Cited by 143
Beshir, K. B., Sutherland, C. J., Sawa, P., DRAKELEY, C. J., Okell, L., Mweresa, C. K., Omar, S. A., Shekalaghe, S., Kaur, H., Ndaro, A. J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit431 · Cited by 136
“cytes are derived [8] and because the artemisinin-component of ACT is given over 3 days, during which it efficiently clears developing gametocytes [8, 35], it is striking that parasite-”
BackgroundTsou, L. K., Lara-Tejero, M., RoseFigura, J. M., Zhang, Z. J., Wang, Y., Yount, J. S., Lefebre, M. D., Dossa, P. D., Kato, J., Guan, F., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b11575 · Cited by 133
Oh, S. K. W., Kim, B. J., Singh, N. P., Lai, H. C., & Sasaki, T. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.031 · Cited by 131
“in the early 1970s, is now widely used as an anti-malarial [2–7].”
BackgroundRecent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum
O’Brien, C., Henrich, P. P., Passi, N. N., & Fidock, D. A. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834cd3ed · Cited by 134
den Steen, P. E. V., Geurts, N., Deroost, K., Aelst, I. V., Verhenne, S., Heremans, H., Damme, J. V., & Opdenakker, G. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0786oc · Cited by 128
Straimer, J., Gnädig, N. F., Stokes, B. H., Ehrenberger, M. A., Crane, A., & Fidock, D. A. (2017) · mBio · doi:10.1128/mbio.00172-17 · Cited by 133
“necessitating the addition of a longer-lasting partner drug to clear the infection (3).”
BackgroundNadjm, B., & Behrens, R. H. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.03.010 · Cited by 169
“In addition, by killing the early ring forms, artemisinin derivatives are able to prevent the development of the more mature trophozoites and schizonts that sequester and cause severe disease.(47) Globally, the main challenges in the treatment of malaria are delivering these lifesaving drugs to the poor and vulnerable…”
BackgroundSonntag, F., Kroner, C., Lubuta, P., Peyraud, R., Horst, A., Buchhaupt, M., & Schrader, J. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.09.004 · Cited by 128
“…interest as biological resources for the industrialized society: many compounds have important applications, e.g. artemisinin and taxol as drugs (White, 2008), (-)-menthol as flavor and fragrance compound (Hanson and Hanson, 1996) and farnesene as biofuel precursor (Renninger and McPhee, 2008).”
BackgroundGozari, M., Alborz, M., El-Seedi, H. R., & Jassbi, A. R. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112957 · Cited by 131
Malaria trends and challenges in the Greater Mekong Subregion.
Delacollette, C., D'Souza, C., Christophel, E. M., Thimasarn, K., Abdur, R., Bell, D., Dai, T. C., Gopinath, D., Lu, S., Mendoza, R., et al. (2009) · PubMed · Cited by 123
Hao, X., Zhong, Y., N�tzmann, H.-W., Fu, X., Yan, T., Shen, Q., Chen, M., Ma, Y., Zhao, J., Osbourn, A., et al. (2019) · Plant and Cell Physiology · doi:10.1093/pcp/pcz084 · Cited by 121
Mita, T., & Tanabe, K. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.465 · Cited by 127
Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu
Zhang, J., Zhang, Q., Liu, G., & Zhang, N. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172710 · Cited by 131
Microbial production of isoprenoids
Chandran, S. S., Kealey, J. T., & Reeves, C. D. (2011) · Process Biochemistry · doi:10.1016/j.procbio.2011.05.012 · Cited by 123
Artemisia Species: From Traditional Medicines to Modern Antimalarials—and Back Again
Willcox, M. L. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0327 · Cited by 156
“23,27 Hence, it cannot be used as a prophylactic.”
Drug-Resistant Malaria: The Era of ACT
Lin, J. T., Juliano, J. J., & Wongsrichanalai, C. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0099-y · Cited by 121
Lu, J., Chen, S.-M., Zhang, X., Ding, J., & Meng, L. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9481-8 · Cited by 119
“ARTs have been widely used as anti-malarial drugs with few side effects [ 1 ], herein we revealed that the main active metabolite of ARTs significantly induced ER stress, suggesting that ATRs should also be tested in its synergistic activity with other anti-cancer drugs.”
BackgroundMethodOnline analysis of in vitro resistance to antimalarial drugs through nonlinear regression
Nagard, H. L., Vincent, C., Mentré, F., & Bras, J. L. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.08.003 · Cited by 118
“[3] N.”
Sawa, P., Shekalaghe, S., DRAKELEY, C. J., Sutherland, C. J., Mweresa, C. K., Baidjoe, A. Y., Manjurano, A. M., Kavishe, R. A., Beshir, K. B., Yussuf, R. U., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit077 · Cited by 114
“highly active against stage I–III gametocytes and has incomplete activity against stage IV and V gametocytes [40, 42].”
BackgroundSurveillance-response systems: the key to elimination of tropical diseases
Tambo, E., Ai, L., Xia, Z., Chen, J., Hu, W., Bergquist, R. N., Guo, J.-G., Utzinger, J., Tanner, M., & Zhou, X. (2014) · Infectious Diseases of Poverty · doi:10.1186/2049-9957-3-17 · Cited by 116
“tribendimidine) [61-63].”
Malhotra, K., Subramani, M., Rawat, K., Kalamuddin, M., Qureshi, M. I., Malhotra, P., Mohmmed, A., Cornish, K., Daniell, H., & Kumar, S. B. (2016) · Molecular Plant · doi:10.1016/j.molp.2016.09.013 · Cited by 120
“Low yields of artemisinin from crop-based production systems and the high cost of chemical synthesis, make these approaches impractical for commercial production (Enserink, 2005; White, 2008).”
BackgroundAllergens of weed pollen: An overview on recombinant and natural molecules
Gadermaier, G., Hauser, M., & Ferreira, F. (2013) · Methods · doi:10.1016/j.ymeth.2013.06.014 · Cited by 119
Metadata
- Authors
- White, N. J.
- Affiliations
- Mahidol University (TH)
- Corresponding author
- White, N. J.
- ORCID
- White, N. J.
- Venue
- Science
- Published
- 2008-04-18
- Volume
- 320
- Issue
- 5874
- Pages
- 330-334
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2076029682
- Cited by
- 954
- References
- 53
- Citations by year
- 2026: 17 · 2025: 37 · 2024: 42 · 2023: 32 · 2022: 32 · 2021: 39 · 2020: 86 · 2019: 48 · 2018: 37 · 2017: 57 · 2016: 61 · 2015: 57 · 2014: 41 · 2013: 54 · 2012: 72
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- artemisinin, Artemisia annua, artemisinin-based combination therapy, antimalarial drugs, drug affordability, malaria treatment, falciparum malaria, artemisinin resistance, agricultural practices, drug pricing
- MeSH terms
- Animals, Antimalarials, Drug Resistance, Drug Therapy, Combination, Health Services Accessibility, Humans, Plasmodium falciparum, Drug Costs, Malaria, Falciparum, Cost of Illness, Artemisia, Artemisinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.